HHS, Walgreens partner on 1st decentralized COVID shot trial

Walgreens has received $25 million in federal funding to conduct a decentralized clinical trial on COVID-19 vaccine immunity. 

Advertisement

About 20 Walgreens stores in geographically diverse regions across the U.S. will serve as clinical trial sites. This approach aims to increase access to clinical trials and create a more diverse pool of research participants. 

The Biomedical Advanced Research and Development Authority is providing the funding as part of Project NextGen. The $5 billion initiative led by HHS’ Administration for Strategic Preparedness and Response aims to develop public-private partnerships to create more effective, longer-lasting COVID-19 vaccines and treatments. 

The agreement is BARDA’s first partnership with a major retail pharmacy to use a decentralized clinical trial approach. 

Learn more here.

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Register to Attend Webinar

The Performance Gap Your Pharmacy Training Metrics Can’t See

Monday, August 10
12:00 PM - 1:00 PM CDT

Presenters: Michael Alexander, AudirieDr. Tina Moen, PharmD, Colibri Healthcare

Advertisement

Next Up in Pharmacy

Advertisement

Comments are closed.